Presentation and Status in Health Basket
Presentation | Basket | Yarpa | Pharmasoft |
---|---|---|---|
Capsules 1 X 150 mg |
78352 | 6424 |
Related information
Dosage
See prescribing information for full details.
Indications
Cryptococcosis, including cryptococcal meningitis. Normal hosts and patients with AIDS, organ transplants or other causes of immunosuppression may be treated. Can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with AIDS.Systemic candidiasis, including candidemia, disseminated candidiasis and other forms of invasive candidal infection. These include infections of the peritoneum, endocardium, pulmonary and urinary tracts. Patients with malignancy, in intensive care units, patients receiving cytotoxic or immunosuppressive therapy, or with other factors predisposing to candidal infections may be treated.Mucosal candidiasis. These include oropharyngeal, esophageal, non-invasive bronchopulmonary infections, candiduria, mucocutaneous and chronic oral atrophic candidiasis (denture sore mouth). Normal hosts and patients with compromised immune function may be treated.Vaginal candidiasis, acute or recurrent.Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and candida infections where topical therapy is considered inappropriate due to the site, severity or extent of the infection.
Contra-Indications
Patients with known hypersensitivity to the drug or to related triazole compounds. Coadministration of terfenadine is contraindicated in patients receiving fluconazole at multiple doses of 400 mg per day or higher, based upon results of a multiple dose interaction study. Coadministration of cisapride is contraindicated in patients receiving fluconazole.
Special Precautions
Please contact distributing company for full details.
Side Effects
Please contact distributing company for full details.
Drug interactions
Please contact distributing company for full details.